31 results
DRS/A
EX-10.15
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
Union or Switzerland, in which case Distributor shall refrain from making active sales of the Products to Customers in the Reserved Territories … performance under this Agreement.
Where the Territory is within the European Union, the provisions of this Section C shall apply for the term
S-1
EX-10.15
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
Union or Switzerland, in which case Distributor shall refrain from making active sales of the Products to Customers in the Reserved Territories … performance under this Agreement.
Where the Territory is within the European Union, the provisions of this Section C shall apply for the term
8-K
EX-2.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
, director, manager, independent contractor or consultant, (3) collective bargaining or other agreement with a union, in each case whether written … voluntary recognition to any labor union for purposes of collective bargaining;
(x)made any change in accounting methods or principles;
(xi)purchased any
DRS/A
EX-10.14
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country … participating member state of the European Union and, with respect to any Foreign Subsidiaries, other currencies held by such Foreign Subsidiary
S-1
EX-10.14
e3fw3 txgih3i06p
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.13
18fk6wzu0ekjvuq 33
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.24
cqcwrdsyxo zg
23 Oct 20
Draft registration statement (amended)
12:00am
8-K
EX-10.1
3qeudtffczw
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
S-1
EX-10.24
9ypd0
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.13
348qj9t8 2e8exh3i
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.16
sgjed
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.16
snpsyp9i0nuo2kqd5
29 Oct 20
IPO registration
5:04pm
10-K
otra414
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
bljx9w
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
at4xvodampo lldep
23 Nov 20
Prospectus supplement with pricing info
4:36pm